PathRight Medical, ,Inc.

PathRight Medical Inc. manufactures specialized medical devices for urological conditions and post-surgical recovery. Founded in 2015 in cooperation with Mayo Clinic, the company develops FDA-cleared and CE-marked devices focused on men's sexual health and urological treatment. Core offerings include RestoreX and RestoreXL penile traction therapy devices for treating Peyronie's disease, correcting penile curvature, and restoring length loss from prostate surgery or trauma. The company also offers PeyroniesGene, the first commercially available genetic test for Peyronie's disease markers, and SnipCheck, a post-vasectomy sperm analysis kit performed by CLIA-certified laboratories. All devices are FSA/HSA eligible, support insurance reimbursement, and ship in discreet packaging. Products require 30–60 minutes daily use and are designed for home-based therapy with clinical validation in peer-reviewed journals including BJU International.